| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |